News

Find News

Filter articles

Applied Filters

Showing 41 to 50 of 129 results

AstraZeneca forms health tech partnerships in China

China06-02-2018

AstraZeneca has announced partnerships with Chinese companies Alibaba and Tencent, in agreements that will use emerging technologies to improve healthcare in China.

Abe & Partners makes two promotions

Japan23-01-2018

Japan-based Abe & Partners has promoted Michiko Kinoshita as partner and Tomohiro Kazama as counsel.

Tilleke & Gibbins promotes IP enforcement specialist

Vietnam10-01-2018

Southeast Asia-based law firm Tilleke & Gibbins has appointed an IP enforcement specialist to partner.

Aslan acquires global rights to cancer treatment

Singapore04-01-2018

Singapore-based Aslan Pharmaceuticals has acquired the full global rights to develop, manufacture and commercialise a cancer treatment.

Pfizer and Basilea extend Cresemba licence agreement to Asia-Pacific

China07-12-2017

Basilea Pharmaceutica and Pfizer have reached a deal for a licence agreement for the antifungal medication Cresemba to cover China and 16 countries in the Asia-Pacific region.

Sanofi leads the way for gene therapy patents: report

International18-10-2017

CPA Global has found that Sanofi files the most patents covering human gene therapy and also spends the most on them overall.

AIPPI 2017: Eli Lilly counsel discusses ‘convoluted’ Amgen v Sanofi ruling

US17-10-2017

A patent counsel at Eli Lilly discussed a recent dispute pitting Amgen against Sanofi and Regeneron, saying an appeals court ruling was convoluted.

WIPO and pharma industry join forces to promote patent access

International03-10-2017

The World Intellectual Property Organization (WIPO) has partnered with trade group the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) to boost access to patent information.

Australian government rejects recommendations on patent extension reform

Australia31-08-2017

The Australian government has rejected proposals by the Productivity Commission regarding extending the length of pharmaceutical patents.

Samsung makes move into novel drugs market

Japan, South Korea22-08-2017

Samsung’s biopharmaceutical arm Samsung Bioepis has agreed a deal with Takeda to tackle “unmet disease areas”, marking the South Korean company’s move into the novel drugs market.

Showing 41 to 50 of 129 results

LSIPR